P2X receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
暂无分享,去创建一个
Francesco Di Virgilio | Richard J. Evans | Simonetta Falzoni | Michael F. Jarvis | Charles Kennedy | Baljit S. Khakh | Brian F. King | Patrizia Pellegatti | John A. Peters | B. Khakh | F. Di Virgilio | J. A. Peters | R. Evans | M. Jarvis | C. Kennedy | S. Falzoni | B. King | P. Pellegatti
[1] M. Rubio,et al. Distinct Localization of P2X Receptors at Excitatory Postsynaptic Specializations , 2001, The Journal of Neuroscience.
[2] A. Ford,et al. A quantitative analysis of purinoceptor expression in human fetal and adult bladders. , 2001, The Journal of urology.
[3] S. Nakanishi,et al. OFF‐cholinergic‐pathway‐selective localization of P2X2 purinoceptors in the mouse retina , 2004, The Journal of comparative neurology.
[4] D. Donnelly-roberts,et al. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout mice , 2009, Behavioural Brain Research.
[5] G. Burnstock,et al. P 2 X 2 and P 2 X 3 purinoceptors in the rat enteric nervous system , 2004 .
[6] J. Wiley,et al. Detection of P 2 X purinergic receptors on human B-lymphocytes , 2016 .
[7] F. Di Virgilio,et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. , 1996, Journal of immunology.
[8] G. Burnstock,et al. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors. , 2001, Journal of medicinal chemistry.
[9] J. Vermylen,et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. , 2003, Blood.
[10] I. Fearon,et al. Expression of P2X2 and P2X3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling , 2001, The Journal of physiology.
[11] F. Natt,et al. Functional Downregulation of P2X3 Receptor Subunit in Rat Sensory Neurons Reveals a Significant Role in Chronic Neuropathic and Inflammatory Pain , 2002, The Journal of Neuroscience.
[12] F. Di Virgilio,et al. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7 , 2017, EJNMMI Research.
[13] F. Markwardt,et al. Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors. , 2000, European journal of pharmacology.
[14] J. Chemin,et al. P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties , 2012, The Journal of Neuroscience.
[15] G Burnstock,et al. Guinea‐pig sympathetic neurons express varying proportions of two distinct P2X receptors , 2000, The Journal of physiology.
[16] S. Petrou,et al. An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 Receptor* , 2003, The Journal of Biological Chemistry.
[17] Geoffrey Burnstock,et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X 3-deficient mice , 2000, Nature.
[18] R. North,et al. An antagonist‐insensitive P2X receptor expressed in epithelia and brain. , 1996, The EMBO journal.
[19] C. Soeller,et al. Expression of the P2X2 Receptor Subunit of the ATP-Gated Ion Channel in the Cochlea: Implications for Sound Transduction and Auditory Neurotransmission , 1999, The Journal of Neuroscience.
[20] G. Burnstock,et al. P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. , 2009, Journal of the American Society of Nephrology : JASN.
[21] F. Virgilio,et al. The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner* , 2008, Journal of Biological Chemistry.
[22] A. Nicke,et al. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand‐gated ion channels , 1998, The EMBO journal.
[23] J. Wyatt,et al. Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats , 2002, PAIN.
[24] G Burnstock,et al. Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors , 1999, British journal of pharmacology.
[25] J. Grosche,et al. P2X7 Receptor Expression after Ischemia in the Cerebral Cortex of Rats , 2004, Journal of neuropathology and experimental neurology.
[26] P. Séguéla,et al. Post-translational regulation of P2X receptor channels: modulation by phospholipids , 2013, Front. Cell. Neurosci..
[27] R. North,et al. Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals , 1997, Neuropharmacology.
[28] D. Hume,et al. ATP Signaling Is Crucial for Communication from Taste Buds to Gustatory Nerves , 2022 .
[29] R. Evans,et al. P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. , 2002, Molecular pharmacology.
[30] G. Tonon,et al. Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. , 2001, Blood.
[31] R. North,et al. Subunit Arrangement in P2X Receptors , 2003, The Journal of Neuroscience.
[32] Maho Shibata,et al. Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons. , 2010, Investigative ophthalmology & visual science.
[33] K. Jacobson,et al. Purine and pyrimidine (P2) receptors as drug targets. , 2002, Journal of medicinal chemistry.
[34] P. Insel,et al. Autocrine regulation of T‐cell activation by ATP release and P2X7 receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] G. Burnstock,et al. A P2X purinoceptor expressed by a subset of sensory neurons , 1995, Nature.
[36] G. Burnstock,et al. Multiple P2X receptors on guinea‐pig pelvic ganglion neurons exhibit novel pharmacological properties , 2001, British journal of pharmacology.
[37] S. Antonarakis,et al. Gene structure and chromosomal localization of the human P2X7 receptor. , 1998, Receptors & channels.
[38] Sarah A. Middleton,et al. The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts , 2017, Scientific Reports.
[39] G. Burnstock,et al. Changes in expression of P2X1 receptors and connexin 43 in the rat myometrium during pregnancy. , 2007, Fertility and sterility.
[40] E. Barnard,et al. Cloning and functional characterisation of the mouse P2X7 receptor , 1998, FEBS letters.
[41] F. Di Virgilio,et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[42] J. Cazenave,et al. Presence of P2X1 Purinoceptors in Human Platelets and Megakaryoblastic Cell Lines , 1997, Thrombosis and Haemostasis.
[43] G. Burnstock,et al. P2X7 Receptors Are Expressed during Mouse Nephrogenesis and in Collecting Duct Cysts of the cpk/cpk Mouse , 2002, Nephron Experimental Nephrology.
[44] S. Govindarajan,et al. P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis1 , 2006, The Journal of Immunology.
[45] A. Ford,et al. A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction , 2001, BJU international.
[46] G. Burnstock,et al. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. , 1998, Journal of medicinal chemistry.
[47] V. Trinkaus-Randall,et al. Regulation by P2X7: epithelial migration and stromal organization in the cornea. , 2008, Investigative ophthalmology & visual science.
[48] S. Douglas,et al. P2X1 stimulation promotes thrombin receptor‐mediated platelet aggregation , 2006, Journal of thrombosis and haemostasis : JTH.
[49] W. Kussmaul,et al. Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. V. Role of purinergic receptors. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[50] Evgeny M. Zdobnov,et al. OrthoDB v9.1: cataloging evolutionary and functional annotations for animal, fungal, plant, archaeal, bacterial and viral orthologs , 2016, Nucleic Acids Res..
[51] J. Gu,et al. Expression of adenosine triphosphate P2X3 receptors in rat molar pulp and trigeminal ganglia. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[52] G. Burnstock. Purine-mediated signalling in pain and visceral perception. , 2001, Trends in pharmacological sciences.
[53] B. Ryffel,et al. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. , 2010, American journal of respiratory and critical care medicine.
[54] K. Fitzgerald,et al. Inflammasome Complexes: Emerging Mechanisms and Effector Functions , 2016, Cell.
[55] Yu-Qiu Zhang,et al. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses , 2010, Brain, Behavior, and Immunity.
[56] D. Cockayne,et al. Enhanced thermal avoidance in mice lacking the ATP receptor P2X3 , 2005, Pain.
[57] F. Di Virgilio,et al. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[58] J. Hoenderop,et al. P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis , 2016, PloS one.
[59] H. Kita,et al. ATP drives eosinophil effector responses through P2 purinergic receptors. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[60] W. Stühmer,et al. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors , 1999, Neuropharmacology.
[61] S. M. Sims,et al. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. , 2003, Molecular endocrinology.
[62] G. Burnstock,et al. Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. , 1999, Neuroreport.
[63] D. Cockayne,et al. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP , 2005, The Journal of physiology.
[64] M. Voigt,et al. Gene structure, chromosomal localization, cDNA cloning and expression of the mouse ATP-gated ionotropic receptor P2X5 subunit. , 2001, Gene.
[65] J. Gillespie,et al. A Putative Alternatively Spliced Variant of the P2X1 Purinoreceptor in Human Bladder , 2000, Experimental physiology.
[66] E. Gouaux,et al. X-ray structures define human P2X3 receptor gating cycle and antagonist action , 2016, Nature.
[67] S. Feske,et al. Ion channelopathies of the immune system. , 2018, Current opinion in immunology.
[68] R. Evans,et al. A study of P 2 X 1 receptor function in murine megakaryocytes and human platelets reveals synergy with P 2 Y receptors , 2002 .
[69] G. Dubyak,et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP , 2016, Nature Communications.
[70] A. Nicke,et al. Heteromeric assembly of P2X subunits , 2013, Front. Cell. Neurosci..
[71] M. Rubio,et al. Fe65 Interacts with P2X2 Subunits at Excitatory Synapses and Modulates Receptor Function* , 2006, Journal of Biological Chemistry.
[72] G. Housley,et al. Distribution of the P2X2 receptor subunit of the ATP‐gated ion channels in the rat central nervous system , 1999, The Journal of comparative neurology.
[73] G. Burnstock,et al. P2X purinoceptors in postmortem human cerebral arteries. , 1998, Journal of cardiovascular pharmacology.
[74] T. Hedner,et al. Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. , 1999, Life sciences.
[75] D. Erlinge,et al. Increased Mitogenic and Decreased Contractile P2 Receptors in Smooth Muscle Cells by Shear Stress in Human Vessels With Intact Endothelium , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[76] Catherine Vial,et al. A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo , 2003, The Journal of experimental medicine.
[77] Â. R. Tomé,et al. Electrophysiological and Immunocytochemical Evidence for P2X Purinergic Receptors in Pancreatic &bgr; Cells , 2008, Pancreas.
[78] D. Zaykin,et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity , 2012, Nature Medicine.
[79] J. Linden,et al. Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.
[80] M. Hattori,et al. Molecular mechanism of ATP binding and ion channel activation in P2X receptors , 2012, Nature.
[81] D. Cockayne,et al. Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit , 2003, The Journal of physiology.
[82] G. Schuler,et al. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto‐nucleotidases , 1999, FEBS letters.
[83] K. Jacobson,et al. Development of selective agonists and antagonists of P2Y receptors , 2008, Purinergic Signalling.
[84] A. Surprenant,et al. Pannexin-1 Couples to Maitotoxin- and Nigericin-induced Interleukin-1β Release through a Dye Uptake-independent Pathway* , 2007, Journal of Biological Chemistry.
[85] A Townsend-Nicholson,et al. Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. , 1998, American journal of physiology. Renal physiology.
[86] P. Séguéla,et al. Modulation of heteromeric P2X1/5 receptors by phosphoinositides in astrocytes depends on the P2X1 subunit , 2010, Journal of neurochemistry.
[87] V. Lagente,et al. Purinergic receptors: new targets for the treatment of gout and fibrosis , 2017, Fundamental & clinical pharmacology.
[88] G. Burnstock,et al. The purinergic component of human vas deferens contraction. , 2006, Fertility and sterility.
[89] D. Donnelly-roberts,et al. A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.
[90] F. Di Virgilio,et al. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. , 2011, American journal of respiratory cell and molecular biology.
[91] W. Wier,et al. Purinergic and Adrenergic Ca2+ Transients during Neurogenic Contractions of Rat Mesenteric Small Arteries , 2003, The Journal of physiology.
[92] B. Sperlágh,et al. P2X7 receptor-mRNA and -protein in the mouse retina; changes during retinal degeneration in BALBCrds mice , 2005, Neurochemistry International.
[93] R. Murrell-Lagnado,et al. The trafficking and targeting of P2X receptors , 2013, Front. Cell. Neurosci..
[94] A Townsend-Nicholson,et al. Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors. , 1999, Brain research. Molecular brain research.
[95] A. Conigrave,et al. Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor , 2004, British journal of pharmacology.
[96] R. North,et al. Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[97] M. Miras-Portugal,et al. Presence of diverse functional P2X receptors in rat cerebellar synaptic terminals. , 2005, Biochemical pharmacology.
[98] R. North,et al. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP , 1994, Nature.
[99] B. Khakh,et al. ATP Modulation of Excitatory Synapses onto Interneurons , 2003, The Journal of Neuroscience.
[100] R. Hodges,et al. Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland. , 2009, Investigative Ophthalmology and Visual Science.
[101] J. Furness,et al. The distribution of P2X3 purine receptor subunits in the guinea pig enteric nervous system , 2002, Autonomic Neuroscience.
[102] P. Bonaventure,et al. Neuropharmacology and analgesia A novel radioligand for the ATP-gated ion channel P 2 X 7 : [ 3 H ] JNJ-54232334 , 2015 .
[103] Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.
[104] F. Di Virgilio,et al. The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.
[105] B S Khakh,et al. Allosteric Control of Gating and Kinetics at P2X4Receptor Channels , 1999, The Journal of Neuroscience.
[106] Edward W Inscho,et al. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. , 2003, The Journal of clinical investigation.
[107] B. Khakh,et al. Patch–clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels , 2008, Proceedings of the National Academy of Sciences.
[108] N. Chauret,et al. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. , 2019, Pulmonary pharmacology & therapeutics.
[109] F. Di Virgilio,et al. The Antibiotic Polymyxin B Modulates P2X7 Receptor Function1 , 2004, The Journal of Immunology.
[110] G. Burnstock,et al. Purinergic signalling and immune cells , 2014, Purinergic Signalling.
[111] J. Vermylen,et al. A Natural Dominant Negative P2X1 Receptor Due to Deletion of a Single Amino Acid Residue* , 2000, The Journal of Biological Chemistry.
[112] C. Lecut,et al. P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice. , 2014, Blood.
[113] M. Seman,et al. Cutting Edge: A Natural P451L Mutation in the Cytoplasmic Domain Impairs the Function of the Mouse P2X7 Receptor1 , 2002, The Journal of Immunology.
[114] G. Burnstock,et al. Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia , 1998, Neuroscience Letters.
[115] A Pelleg,et al. Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals. , 1996, The Journal of physiology.
[116] F. Di Virgilio. P2RX7: A receptor with a split personality in inflammation and cancer , 2016, Molecular & cellular oncology.
[117] G. Burnstock,et al. Differential expression of P2X receptors on neurons from different parasympathetic ganglia , 2005, Neuropharmacology.
[118] J. Wiley,et al. Extracellular ATP Increases Cation Fluxes in Human Erythrocytes by Activation of the P2X7 Receptor* , 2004, Journal of Biological Chemistry.
[119] P. Barnes,et al. Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases. , 2016, Chest.
[120] J. Brown,et al. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors , 2000, Nature.
[121] K. M. Spyer,et al. Pivotal Role of Nucleotide P2X2 Receptor Subunit of the ATP-Gated Ion Channel Mediating Ventilatory Responses to Hypoxia , 2003, The Journal of Neuroscience.
[122] J. Gever,et al. AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist , 2010, British journal of pharmacology.
[123] R. Gómez-Villafuertes,et al. Axodendritic fibres of mouse cerebellar granule neurons exhibit a diversity of functional P2X receptors , 2009, Neurochemistry International.
[124] E. Kawashima,et al. Tissue distribution of the P2X7 receptor , 1997, Neuropharmacology.
[125] H. de la Salle,et al. The P2X1 Receptor Is Required for Neutrophil Extravasation during Lipopolysaccharide-Induced Lethal Endotoxemia in Mice , 2015, The Journal of Immunology.
[126] J. Furness,et al. The distribution of purine P2X(2) receptors in the guinea-pig enteric nervous system. , 2002, Histochemistry and cell biology.
[127] W. Stühmer,et al. Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. , 1997, Molecular pharmacology.
[128] H. Tozaki-Saitoh,et al. A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain , 2016, Scientific Reports.
[129] R. North,et al. P2X1 and P2X5 Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes , 2008, The Journal of Neuroscience.
[130] M. Ikeda,et al. Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[131] A. Colomar,et al. ATP stimulation of P2X7 receptors activates three different ionic conductances on cultured mouse Schwann cells , 2001, The European journal of neuroscience.
[132] D. Ferrari,et al. ATP-mediated cytotoxicity in microglial cells , 1997, Neuropharmacology.
[133] M. Kassack,et al. Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist. , 2004, European journal of medicinal chemistry.
[134] T. Kawate,et al. Structural basis for subtype-specific inhibition of the P2X7 receptor , 2016, eLife.
[135] W. Stühmer,et al. Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. , 1997, Brain research. Molecular brain research.
[136] Robert Elde,et al. Distinct ATP receptors on pain-sensing and stretch-sensing neurons , 1997, Nature.
[137] S. Fleischer,et al. Calcium signalling through nucleotide receptor P2X1 in rat portal vein myocytes , 2001, The Journal of physiology.
[138] Graham L. Collingridge,et al. A nomenclature for ligand-gated ion channels , 2009, Neuropharmacology.
[139] J. Gever,et al. Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red , 2005, British journal of pharmacology.
[140] M. Heath,et al. Identification of a P2X1 purinoceptor expressed on human platelets. , 1998, Biochemical and biophysical research communications.
[141] K. Limesand,et al. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy , 2017, The Journal of Biological Chemistry.
[142] M. Braddock,et al. Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373 , 2006, British journal of pharmacology.
[143] J. Yamazaki,et al. Presence and possible role of the spliced isoform of the P2X1 receptor in rat vascular smooth muscle cells , 2000, Pflügers Archiv.
[144] G. Housley,et al. Immunohistochemical localization of adenosine 5`‐triphosphate‐gated ion channel P2X2 receptor subunits in adult and developing rat cochlea , 2000, The Journal of comparative neurology.
[145] G. Burnstock,et al. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. , 2003, The Journal of investigative dermatology.
[146] D. Donnelly-roberts,et al. Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states , 2007, British journal of pharmacology.
[147] P. Bonaventure,et al. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567 , 2013, British journal of pharmacology.
[148] Emma J. Kidd,et al. Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X 3 receptors , 2000, Nature.
[149] A. Gartland,et al. Blockade of the Pore-Forming P2X7 Receptor Inhibits Formation of Multinucleated Human Osteoclasts In Vitro , 2003, Calcified Tissue International.
[150] S. Greenfeder,et al. Identification and characterization of splice variants of the human P2X7 ATP channel. , 2005, Biochemical and biophysical research communications.
[151] F. Di Virgilio,et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells , 2007, Nature Medicine.
[152] F. Symon,et al. Impaired P2X1 Receptor–Mediated Adhesion in Eosinophils from Asthmatic Patients , 2016, The Journal of Immunology.
[153] F. Di Virgilio,et al. A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes1 , 2005, The Journal of Immunology.
[154] G. Housley,et al. ATP-gated ion channels assembled from P2X2 receptor subunits in the mouse cochlea , 2002, Neuroreport.
[155] G. Burnstock,et al. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats , 2003, Molecular and Cellular Endocrinology.
[156] S. Petrou,et al. An Arg307 to Gln Polymorphism within the ATP-binding Site Causes Loss of Function of the Human P2X7 Receptor* , 2004, Journal of Biological Chemistry.
[157] D. Kumararatne,et al. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. , 2002, Journal of immunology.
[158] E A Barnard,et al. Localization and functional expression of splice variants of the P2X2 receptor. , 1997, Molecular pharmacology.
[159] J. Deuchars,et al. An evaluation of antibody detection of the P2X1 receptor subunit in the CNS of wild type and P2X1-knockout mice , 2006, Neuroscience Letters.
[160] S. Antonarakis,et al. Characterization and chromosomal localization of a human P2X receptor from the urinary bladder. , 1995, Receptors & channels.
[161] R. Evans,et al. P2X Receptor Immunoreactivity in Different Arteries from the Femoral, Pulmonary, Cerebral, Coronary and Renal Circulations , 2001, Journal of Vascular Research.
[162] R. North,et al. Pharmacological and biophysical properties of the human P2X5 receptor. , 2003, Molecular pharmacology.
[163] R Elde,et al. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[164] C. Gargett,et al. The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytes , 1997, British journal of pharmacology.
[165] Y. Lin,et al. Mediator mechanisms involved in TRPV1 and P2X receptor-mediated, ROS-evoked bradypneic reflex in anesthetized rats. , 2006, Journal of applied physiology.
[166] Geoffrey Burnstock,et al. A P2X purinoceptor cDNA conferring a novel pharmacological profile , 1995, FEBS letters.
[167] Eric Gouaux,et al. Pore architecture and ion sites in acid sensing ion channels and P2X receptors , 2009, Nature.
[168] R. North,et al. Reanalysis of P2X7 Receptor Expression in Rodent Brain , 2004, The Journal of Neuroscience.
[169] M. Schaefer,et al. Clemastine Potentiates the Human P2X7 Receptor by Sensitizing It to Lower ATP Concentrations* , 2011, The Journal of Biological Chemistry.
[170] C. Brosnan,et al. The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes , 2005, Glia.
[171] P. Séguéla,et al. A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[172] P. Anand,et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.
[173] A. Farce,et al. Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease. , 2020, Journal of medicinal chemistry.
[174] F. Di Virgilio,et al. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. , 2006, Cancer research.
[175] J. Simon,et al. Species and response dependent differences in the effects of MAPK inhibitors on P2X7 receptor function , 2006, British journal of pharmacology.
[176] K. Kohler,et al. Expression of the P2X7-receptor subunit in neurons of the rat retina. , 1998, Brain research. Molecular brain research.
[177] B. Robertson,et al. P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease* , 2003, The Journal of Biological Chemistry.
[178] E. Gouaux,et al. Crystal structure of the ATP-gated P2X4 ion channel in the closed state , 2009, Nature.
[179] F. Di Virgilio,et al. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. , 1993, The Journal of biological chemistry.
[180] R. Doctor,et al. Characterization of ionotrophic purinergic receptors in hepatocytes , 2007, Hepatology.
[181] Michael F. Jarvis,et al. ISSUE IN MEMORY OF AVRAM GOLDSTEIN P 2 X Receptors as Drug Targets , 2013 .
[182] R. North,et al. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons , 1995, Nature.
[183] G. Burnstock,et al. P2X receptor immunoreactivity in the rat cochlea, vestibular ganglion and cochlear nucleus , 1999, Hearing Research.
[184] J. Gever,et al. Pharmacology of P2X channels , 2006, Pflügers Archiv.
[185] N. Alexis,et al. Extracellular purines are biomarkers of neutrophilic airway inflammation , 2008, European Respiratory Journal.
[186] S. Fuller,et al. A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1–2% of the Caucasian population , 2005, FEBS letters.
[187] R. Evans,et al. P 2 X 1 Receptor-Deficient Mice Establish the Native P 2 X Receptor and a P 2 Y 6-Like Receptor in Arteries , 2002 .
[188] T. van Biesen,et al. Molecular and functional characterization of human P2X(2) receptors. , 1999, Molecular pharmacology.
[189] Annette Nicke,et al. Molecular and functional properties of P2X receptors—recent progress and persisting challenges , 2012, Purinergic Signalling.
[190] P. Anand,et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord , 2006, BMC neurology.
[191] D. Walter,et al. Negative and positive allosteric modulators of the P2X(7) receptor. , 2008, British journal of pharmacology.
[192] R. North,et al. Trinitrophenyl-Substituted Nucleotides Are Potent Antagonists Selective for P 2 X 1 , P 2 X 3 , and Heteromeric P 2 X 2 / 3 Receptors , 1998 .
[193] A. Michel,et al. Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors. , 2006, European journal of pharmacology.
[194] S. McMahon,et al. The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. , 1998, Molecular and cellular neurosciences.
[195] R. North,et al. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. , 2000, Molecular pharmacology.
[196] K. Jacobson,et al. Medicinal chemistry of adenosine, P2Y and P2X receptors , 2016, Neuropharmacology.
[197] G. Burnstock,et al. Expression of P2X and P2Y receptors in the intramural parasympathetic ganglia of the cat urinary bladder. , 2006, American journal of physiology. Renal physiology.
[198] Beverly H. Koller,et al. Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.
[199] C. Takiya,et al. The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. , 2006, Kidney international.
[200] C. Yoshioka,et al. Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization , 2019, Cell.
[201] S. Senger,et al. Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor. , 2010, Bioorganic & medicinal chemistry letters.
[202] D. Donnelly-roberts,et al. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors , 2009, British journal of pharmacology.
[203] P. Séguéla,et al. Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system , 1997, FEBS letters.
[204] C. Gabel,et al. Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response , 2002, The Journal of Immunology.
[205] Huafeng Zhang,et al. Endotoxin-induced autocrine ATP signaling inhibits neutrophil chemotaxis through enhancing myosin light chain phosphorylation , 2017, Proceedings of the National Academy of Sciences.
[206] D. Donnelly-roberts,et al. Mitogen-Activated Protein Kinase and Caspase Signaling Pathways Are Required for P2X7 Receptor (P2X7R)-Induced Pore Formation in Human THP-1 Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.
[207] A. Nicke,et al. A Functional P2X7 Splice Variant with an Alternative Transmembrane Domain 1 Escapes Gene Inactivation in P2X7 Knock-out Mice* , 2009, The Journal of Biological Chemistry.
[208] R. Cunha,et al. Dual Presynaptic Control by ATP of Glutamate Release via Facilitatory P2X1, P2X2/3, and P2X3 and Inhibitory P2Y1, P2Y2, and/or P2Y4 Receptors in the Rat Hippocampus , 2005, The Journal of Neuroscience.
[209] S. Seino,et al. Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. , 1996, Biochemical and biophysical research communications.
[210] S. M. Sims,et al. Activity-dependent Development of P2X7 Current and Ca2+ Entry in Rabbit Osteoclasts* , 2001, The Journal of Biological Chemistry.
[211] F. Di Virgilio,et al. The P2X7 receptor: A main player in inflammation , 2017, Biochemical pharmacology.
[212] Q. Zheng. Radioligands targeting purinergic P2X7 receptor. , 2020, Bioorganic & medicinal chemistry letters.
[213] F. Di Virgilio,et al. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. , 1995, The Journal of clinical investigation.
[214] I. Chessell,et al. Blockade of human P2X7 receptor function with a monoclonal antibody. , 1998, Blood.
[215] Identification of regions of the P2X7 receptor that contribute to human and rat species differences in antagonist effects , 2008, British journal of pharmacology.
[216] R. Evans,et al. Smooth muscle does not have a common P2x receptor phenotype: expression, ontogeny and function of P2x1 receptors in mouse ileum, bladder and reproductive systems , 2001, Autonomic Neuroscience.
[217] A. Woolf,et al. The P2X7 ATP receptor modulates renal cyst development in vitro. , 2004, Biochemical and biophysical research communications.
[218] M. Schaefer,et al. Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors , 2012, British journal of pharmacology.
[219] F. Di Virgilio,et al. A role for P2X7 in microglial proliferation , 2006, Journal of neurochemistry.
[220] I. Chessell,et al. Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel alpha beta-methylene ATP-sensitive phenotype. , 2004, Molecular pharmacology.
[221] J. Kamei,et al. Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs. , 2006, European journal of pharmacology.
[222] G. Schmalzing,et al. The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor , 2000, Neuropharmacology.
[223] J. Pintor,et al. Co-localisation of functional nicotinic and ionotropic nucleotide receptors in isolated cholinergic synaptic terminals , 2002, Neuropharmacology.
[224] R. Marée,et al. P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation , 2009 .
[225] C. D. dos Remedios,et al. Increase in expression of P2X1 receptors in the atria of patients suffering from dilated cardiomyopathy , 1999, Electrophoresis.
[226] F. Di Virgilio,et al. Extracellular purines, purinergic receptors and tumor growth , 2016, Oncogene.
[227] F. Di Virgilio. Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target , 2003, British journal of pharmacology.
[228] G. Burnstock,et al. P2X2 and P2X3 receptor expression in the gallbladder of the guinea pig , 2004, Autonomic Neuroscience.
[229] T. Pawełczyk,et al. Purinergic signaling in B cells. , 2018, Acta biochimica Polonica.
[230] B S Khakh,et al. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. , 2001, Pharmacological reviews.
[231] M. Decker,et al. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders , 2009, Behavioural Brain Research.
[232] M. Fox,et al. Structure and chromosomal mapping of the mouse P2X3 gene. , 1997, Gene.
[233] R. Santer,et al. Age-associated changes in distribution of the P2X2 receptor in the major pelvic ganglion of the male rat. , 2006, Neuroscience Letters.
[234] N. Copeland,et al. Structure and chromosome location of the mouse P2X1 purinoceptor gene (P2rx1) , 2001, Cytogenetic and Genome Research.
[235] C. Karschin,et al. P 2 X 4 : An ATP-activated ionotropic receptor cloned from rat brain ( purinergic receptor ) , 2022 .
[236] Yi Dai,et al. Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat , 2005, The Journal of comparative neurology.
[237] F. Di Virgilio,et al. Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.
[238] Gary Layton,et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study , 2015, The Lancet.
[239] G. Burnstock,et al. Ultrastructural localization of P2X3receptors in rat sensory neurons , 1998, Neuroreport.
[240] K. Wareham,et al. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells , 2009, British journal of pharmacology.
[241] T. Tokino,et al. Cloning and characterization of the murine P2XM receptor gene , 1998, Journal of Human Genetics.
[242] D. Davidson,et al. The role of the purinergic P2X7 receptor in inflammation , 2007, Journal of Inflammation.
[243] S. M. Sims,et al. Expression, signaling, and function of P2X7 receptors in bone , 2009, Purinergic Signalling.
[244] S. Petrou,et al. A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 Receptor* , 2001, The Journal of Biological Chemistry.
[245] K. K. Rau,et al. Co-expression of P2X receptor subunits on rat nodose neurons that bind the isolectin GS-I-B4 , 2001, Neuroreport.
[246] J. Bornstein,et al. ATP as a Putative Sensory Mediator: Activation of Intrinsic Sensory Neurons of the Myenteric Plexus via P2X Receptors , 2002, The Journal of Neuroscience.
[247] F. Di Virgilio,et al. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. , 1999, Journal of cell science.
[248] A. Kalgutkar,et al. Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535. , 2011, Bioorganic & medicinal chemistry letters.
[249] G. Hutchins,et al. Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation , 2017, The Journal of Nuclear Medicine.
[250] Geoffrey Burnstock,et al. Coexpression of mRNAs for P2X1, P2X2 and P2X4 Receptors in Rat Vascular Smooth Muscle: An in situ Hybridization and RT-PCR Study , 1998, Journal of Vascular Research.
[251] G. Burnstock,et al. Neurochemical identification of enteric neurons expressing P2X3 receptors in the guinea-pig ileum , 2002, Histochemistry and Cell Biology.
[252] D. Julius,et al. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor , 1994, Nature.
[253] J. Gever,et al. Purinoceptors as therapeutic targets for lower urinary tract dysfunction , 2006, British journal of pharmacology.
[254] A. IJzerman,et al. Pharmacological analysis of ecto‐ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X‐purinoceptor ligands , 1994, British journal of pharmacology.
[255] G. Burnstock,et al. P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. , 2005, International journal of cardiology.
[256] D. Cockayne,et al. P2X2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine , 2003, The Journal of physiology.
[257] F. Di Virgilio,et al. The Elusive P2X7 Macropore. , 2018, Trends in cell biology.
[258] G. Burnstock,et al. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. , 2004, Kidney international.
[259] G. Burnstock,et al. Development of nerves expressing P2X3 receptors in the myenteric plexus of rat stomach , 2004, Histochemistry and Cell Biology.
[260] T. Brennan,et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[261] F. Di Virgilio,et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. , 2002, Blood.
[262] J. Kamei,et al. Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity. , 2005, European journal of pharmacology.
[263] G. Dubyak,et al. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms , 2003, British journal of pharmacology.
[264] Min Zhang,et al. Co‐release of ATP and ACh mediates hypoxic signalling at rat carotid body chemoreceptors , 2000, The Journal of physiology.
[265] F. Di Virgilio,et al. Purines, purinergic receptors, and cancer. , 2012, Cancer research.